title: Lymphocytic vasculitis of the uterus in a patient with melanoma receiving ipilimumab.
authors.affiliation: Center for Melanoma Research and Treatment, California Pacific Medical Center, San Francisco, CA, USA. minord@sutterhealth.org
authors.forename: David R
authors.initials: DR
authors.lastname: Minor
authors.forename: Stephen R
authors.initials: SR
authors.lastname: Bunker
authors.forename: Judith
authors.initials: J
authors.lastname: Doyle
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D001707:Biopsy, Needle; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D007262:Infusions, Intravenous; D000074324:Ipilimumab; D008198:Lymph Nodes / Q000473:pathology*; D008206:Lymphatic Diseases / Q000139:chemically induced* / Q000473:pathology; D008207:Lymphatic Metastasis; D008214:Lymphocytes / Q000473:pathology; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary; D009361:Neoplasm Invasiveness / Q000473:pathology; D035583:Rare Diseases; D012074:Remission Induction; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014599:Uterus / Q000098:blood supply / Q000187:drug effects*; D014657:Vasculitis / Q000139:chemically induced* / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D000074324:Ipilimumab